Skip to main content
SpringerLink
Log in

Carvedilol alleviates testicular and spermatological damage induced by cisplatin in rats via modulation of oxidative stress and inflammation

  • Research Article
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The clinical application of the anticancer drug cisplatin is limited by its deleterious side effects, including male reproductive toxicity. In this context, the potential protective effect of carvedilol on testicular and spermatological damage induced by cisplatin in male Sprague–Dawley rats was investigated. Carvedilol was orally administered at a dose of 10 mg/kg for 2 weeks, and cisplatin was given as a single intraperitoneal injection of 10 mg/kg on the 12th day to induce toxicity. Cisplatin significantly reduced reproductive organ weight, sperm count and sperm motility, and increased sperm abnormalities and histopathological damage of testicular tissue. In addition, it resulted in a significant decline in serum testosterone as well as levels of testicular enzymatic and non-enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxides, and reduced glutathione). Moreover, cisplatin remarkably augmented malondialdehyde, nitric oxide, tumor necrosis factor-α, and nuclear factor-kappa B contents in testicular tissue. Conversely, carvedilol administration markedly mitigated cisplatin-induced testicular and spermatological injury as demonstrated by suppression of oxidative/nitrosative and inflammatory burden, amendment of antioxidant defenses, enhancement of steroidogenesis and spermatogenesis, and mitigation of testicular histopathological damage. The current study reveals a promising protective action of carvedilol against cisplatin-induced reproductive toxicity by virtue of its anti-inflammatory and antioxidant properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Adejuwon SA, Femi-Akinlosotu OM, Omirinde JO (2015) Cisplatin-induced testicular dysfunction and its amelioration by Launaea taraxacifolia leaf extract. Andrologia 47:553–559

    Article  CAS  PubMed  Google Scholar 

  • Ahmed LA, Shehata NI, Abdelkader NF, Khattab MM (2014) Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice. PLoS One 9:e108889

    Article  PubMed  PubMed Central  Google Scholar 

  • Aitken RJ, Curry BJ (2011) Redox regulation of human sperm function: from the physiological control of sperm capacitation to the etiology of infertility and DNA damage in the germ line. Antioxid Redox Signal 14:367–381

    Article  CAS  PubMed  Google Scholar 

  • Alfieri AB, Briceno L, Fragasso G, Spoladore R, Palloshi A, Bassanelli G, Montano C, Arioli F, Cuko A, Ruotolo G, Margonato A (2008) Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure. J Cardiovasc Pharmacol 52:49–54

    Article  CAS  PubMed  Google Scholar 

  • Almaghrabi OA (2015) Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi J Biol Sci 22:227–231

    Article  CAS  PubMed  Google Scholar 

  • Amin A, Hamza AA, Kambal A, Daoud S (2008) Herbal extracts counteract cisplatin-mediated cell death in rat testis. Asian J Androl 10:291–297

    Article  PubMed  Google Scholar 

  • Amin A, Abraham C, Hamza AA, Abdalla ZA, Al-Shamsi SB, Harethi SS, Daoud S (2012) A standardized extract of Ginkgo biloba neutralizes cisplatin-mediated reproductive toxicity in rats. J Biomed Biotechnol. doi:10.1155/2012/362049

  • Arab HH, El-Sawalhi MM (2013) Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: modulation of oxidative stress and inflammatory mediators. Toxicol Appl Pharmacol 268:241–248

    Article  CAS  PubMed  Google Scholar 

  • Arozal W, Watanabe K, Veeraveedu PT, Ma M, Thandavarayan RA, Sukumaran V, Suzuki K, Kodama M, Aizawa Y (2010) Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats. Toxicol 274:18–26

    Article  CAS  Google Scholar 

  • Atessahin A, Sahna E, Turk G, Ceribasi AO, Yilmaz S, Yuce A, Bulmus O (2006) Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. J Pineal Res 41:21–27

    Article  CAS  PubMed  Google Scholar 

  • Bearden HJ, Fluquary J (1980) Applied animal reproduction. Restore Publishing Co. Inc., Reston

    Google Scholar 

  • Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888

    CAS  PubMed  Google Scholar 

  • Beytur A, Ciftci O, Oguz F, Oguzturk H, Yilmaz F (2012) Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. Cancer Chemother Pharmacol 69:207–213

    Article  CAS  PubMed  Google Scholar 

  • Boekelheide K (2005) Mechanisms of toxic damage to spermatogenesis. J Natl Cancer Inst Monogr 34:6–8

    Article  CAS  Google Scholar 

  • Bubici C, Papa S, Dean K, Franzoso G (2006) Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncog 25:6731–6748

    Article  CAS  Google Scholar 

  • Carvalho Rodrigues MA, Silva Faria MC, Santos NA, Gobe GC, Dos Santos AC (2013) Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice. Chem Biol Interact 206:90–99

    Article  CAS  PubMed  Google Scholar 

  • Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61:223–242

    Article  CAS  PubMed  Google Scholar 

  • Ciftci O, Cetin A, Aydin M, Kaya K, Oguz F (2014) Fish oil, contained in eicosapentaenoic acid and docosahexaenoic acid, attenuates testicular and spermatological damage induced by cisplatin in rats. Andrologia 46:1161–1168

    Article  CAS  PubMed  Google Scholar 

  • Dandona P, Ghanim H, Brooks DP (2007) Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens 25:731–741

    Article  CAS  PubMed  Google Scholar 

  • Erdinçler DS, Seven A, Inci F, Beǧer T, Candan G (1997) Lipid peroxidation and oxidant status in experimental animals: effect of aging and hypercholestrolemic diet. Clin Chim Acta 265:77–84

    Article  PubMed  Google Scholar 

  • Fung C, Vaughn DJ (2011) Complications associated with chemotherapy in testicular cancer management. Nat Rev Urol 8:213–222

    Article  CAS  PubMed  Google Scholar 

  • Hamdy N, El-Demerdash E (2012) New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage. Toxicol Appl Pharmacol 261:292–299

    Article  CAS  PubMed  Google Scholar 

  • Hamza AA, Elwy HM, Badawi AM (2016) Fenugreek seed extract attenuates cisplatin-induced testicular damage in Wistar rats. Andrologia 48:211–221

    Article  CAS  PubMed  Google Scholar 

  • Hayashi T, De Velasco MA, Saitou Y, Nose K, Nishioka T, Ishii T, Uemura H (2010) Carvedilol protects tubular epithelial cells from ischemia–reperfusion injury by inhibiting oxidative stress. Int J Urol 17:989–995

    Article  CAS  PubMed  Google Scholar 

  • Ilbey YO, Ozbek E, Simsek A, Otunctemur A, Cekmen M, Somay A (2009) Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats. Fertil Steril 92:1124–1132

    Article  CAS  PubMed  Google Scholar 

  • Kawai Y, Nakao T, Kunimura N, Kohda Y, Gemba M (2006) Relationship of intracellular calcium and oxygen radicals to Cisplatin-related renal cell injury. J Pharmacol Sci 100:65–72

    Article  CAS  PubMed  Google Scholar 

  • Kaya K, Ciftci O, Cetin A, Dogan H, Basak N (2015) Hesperidin protects testicular and spermatological damages induced by cisplatin in rats. Andrologia 47:793–800

    Article  CAS  PubMed  Google Scholar 

  • Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573–584

    Article  CAS  PubMed  Google Scholar 

  • Khan MA, Liu J, Kumar G, Skapek SX, Falck JR, Imig JD (2013) Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. FASEB J 27:2946–2956

    Article  PubMed  PubMed Central  Google Scholar 

  • Kleinert H, Pautz A, Linker K, Schwarz PM (2004) Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500:255–266

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Dogra S (2009) Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat. Pharmacol Biochem Behav 92:25–31

    Article  CAS  PubMed  Google Scholar 

  • Lin P-Y, Shen H-C, Chen C-J, Wu S-E, Kao H-L, Huang J-H, Wang D, Chen S-C (2010) The inhibition in tumor necrosis factor-α-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-κB and reactive oxygen species. J Thromb Thrombolysis 29:52–59

    Article  CAS  PubMed  Google Scholar 

  • Longo V, Gervasi PG, Lubrano V (2011) Cisplatin induced toxicity in rat tissues: the protective effect of Lisosan G. Food Chem Toxicol 49:233–237

    Article  CAS  PubMed  Google Scholar 

  • Migliavacca E, Ancerewicz J, Carrupt P-A, Testa B (1998) Theoretical parameters to characterize antioxidants. Part 2. The cases of melatonin and carvedilol. Helv Chim Acta 81:1337–1348

    Article  CAS  Google Scholar 

  • Naidu PS, Singh A, Kulkarni SK (2002) Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms. Br J Pharmacol 136:193–200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakayama K, Milbourne A, Schover LR, Champlin RE, Ueno NT (2008) Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers. Nat Clin Pract Oncol 5:78–89

    Article  PubMed  Google Scholar 

  • Oliveira PJ, Bjork JA, Santos MS, Leino RL, Froberg MK, Moreno AJ, Wallace KB (2004) Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 200:159–168

    Article  CAS  PubMed  Google Scholar 

  • Parlaktas BS, Atilgan D, Gencten Y, Akbas A, Markoc F, Erdemir F, Ozyurt H, Uluocak N (2014) The effects of carvedilol on ischemia-reperfusion injury in the rat testis. Int Braz J Urol 40:109–117

    CAS  PubMed  Google Scholar 

  • Ramzy MM, El-Sheikh AA, Kamel MY, Abdelwahab SA, Morsy MA (2014) Mechanism of testicular protection of carvedilol in streptozotocin-induced diabetic rats. Indian J Pharmacol 46:161–165

    Article  PubMed  PubMed Central  Google Scholar 

  • Rezvanfar MA, Rezvanfar MA, Shahverdi AR, Ahmadi A, Baeeri M, Mohammadirad A, Abdollahi M (2013) Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles. Toxicol Appl Pharmacol 266:356–365

    Article  CAS  PubMed  Google Scholar 

  • Rodrigues MA, Rodrigues JL, Martins NM, Barbosa F, Curti C, Santos NA, Santos AC (2011) Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. Chem Biol Interact 189:45–51

    Article  CAS  PubMed  Google Scholar 

  • Sahu BD, Koneru M, Bijargi SR, Kota A, Sistla R (2014) Chromium-induced nephrotoxicity and ameliorative effect of carvedilol in rats: involvement of oxidative stress, apoptosis and inflammation. Chem Biol Interact 223C:69–79

    Article  Google Scholar 

  • Salem EA, Salem NA, Maarouf AM, Serefoglu EC, Hellstrom WJ (2012) Selenium and lycopene attenuate cisplatin-induced testicular toxicity associated with oxidative stress in Wistar rats. Urology 79:1184.e1–1184.e6

    Google Scholar 

  • Sari FR, Arozal W, Watanabe K, Harima M, Veeravedu PT, Thandavarayan RA, Suzuki K, Arumugam S, Soetikno V, Kodama M (2011) Carvedilol attenuates inflammatory-mediated cardiotoxicity in daunorubicin-induced rats. Pharmaceuticals 4:551–566

    Article  CAS  PubMed Central  Google Scholar 

  • Savoia C, Schiffrin EL (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci 112:375–384

    Article  CAS  PubMed  Google Scholar 

  • Sherif IO, Abdel-Aziz A, Sarhan OM (2014) Cisplatin-induced testicular toxicity in rats: the protective effect of arjunolic acid. J Biochem Mol Toxicol 28:515–521

    Article  CAS  PubMed  Google Scholar 

  • Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Stahl E, Giwercman A (2006) Sperm DNA integrity in testicular cancer patients. Hum Reprod 21:3199–3205

    Article  CAS  PubMed  Google Scholar 

  • Tak PP, Firestein GS (2001) NF-kappa B: a key role in inflammatory diseases. J Clin Invest 107:7–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Todd RC, Lippard SJ (2009) Inhibition of transcription by platinum antitumor compounds. Metallomics 1:280–291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tomao F, Miele E, Spinelli G, Tomao S (2006) Anticancer treatment and fertility effects. Literature review. J Exp Clin Cancer Res 25:475–481

    CAS  PubMed  Google Scholar 

  • Wilop S, Von Hobe S, Crysandt M, Esser A, Osieka R, Jost E (2009) Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy. J Cancer Res Clin Oncol 135:1429–1435

    Article  CAS  PubMed  Google Scholar 

  • Yang SP, Ho LJ, Lin YL, Cheng SM, Tsao TP, Chang DM, Hsu YL, Shih CY, Juan TY, Lai JH (2003) Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc Res 59:776–787

    Article  CAS  PubMed  Google Scholar 

  • Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115–124

    Article  PubMed  Google Scholar 

  • Yue TL, Cheng HY, Lysko PG, Mckenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G (1992) Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 263:92–98

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Prof. Dr. Bakeir A and Prof. Dr. Ahmed KA (Department of Histology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt) for performing the histopathological and immunohistochemical examinations.

Author information

Authors and Affiliations

  1. Department of Pharmacology, National Organization for Drug Control and Research (NODCAR), Giza, Egypt

    Ahmed H. Eid, Ola M. Abd El-Raouf & Hala M. Fawzy

  2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo, 11562, Egypt

    Noha F. Abdelkader & Ezz-El-Din S. El-Denshary

Authors
  1. Ahmed H. Eid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noha F. Abdelkader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ola M. Abd El-Raouf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hala M. Fawzy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ezz-El-Din S. El-Denshary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noha F. Abdelkader.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eid, A.H., Abdelkader, N.F., Abd El-Raouf, O.M. et al. Carvedilol alleviates testicular and spermatological damage induced by cisplatin in rats via modulation of oxidative stress and inflammation. Arch. Pharm. Res. 39, 1693–1702 (2016). https://doi.org/10.1007/s12272-016-0833-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-016-0833-6

Keywords

Search

Navigation